British Patient Capital

British Patient Capital Limited is a venture capital arm of British Business Bank PLC, established in 2018 and headquartered in Sheffield, with an additional office in London. The company specializes in seed, early venture, mid venture, and growth capital investments, focusing on a diverse range of sectors including information technology, healthcare, financial services, and energy. British Patient Capital primarily invests in UK-based ventures but is also open to global opportunities. The firm aims to finance innovative companies and promote long-term investment strategies that yield competitive returns. It also emphasizes the importance of attracting additional investors to the venture capital space through its commitment to delivering value and managing risk.

Mark Andrews

Investment Director, Life Sciences, Funds

Ian Connatty

Managing Director, Funds

Jake Hobbs

Investment Manager, Life Sciences, Funds

Christine Hockley

Managing Director, Funds

Emma Johnson

Senior Investment Manager, Life Sciences, Direct and Co-Investment

Max Middleton

Senior Investment Manager

Past deals in London

Quantexa

Series F in 2025
Quantexa Limited is a data and analytics software company based in London, United Kingdom, that specializes in entity resolution and network building technology. Founded in 2016, the company offers solutions that include a unified view of customers and networks, as well as tools for fraud detection, compliance, and anti-money laundering. Quantexa's platform utilizes artificial intelligence to integrate siloed data and provide organizations with a contextual understanding of their data landscape, helping to identify risks and opportunities. This technology enables clients across financial services, corporate sectors, and public entities to enhance operational decision-making by automating processes at scale. Additionally, Quantexa has established a strategic alliance with Accenture to further extend its reach and capabilities in the market.

Wagestream

Venture Round in 2024
Wagestream Ltd., established in 2018 and based in London, United Kingdom, offers a financial services application that empowers employees to access their earned wages on demand. This platform enables users to control their payment timing, effectively alleviating the need for advances or loans and reducing financial stress associated with unexpected expenses. Wagestream aims to combat the poverty premium and help employees avoid debt cycles linked to high-interest credit and overdraft fees. The application includes various financial tools designed to improve workplace financial well-being, allowing employees to budget, set savings goals, and manage their financial resources effectively. The company is backed by several investors, including QED, Fair by Design, London Co-Investment Fund, and Village Global.

Curve Therapeutics

Series A in 2024
Curve Therapeutics Limited is a drug-discovery company based in London, United Kingdom, founded in 2019. The company focuses on developing technologies to target currently undruggable disease-modifying targets, with a primary emphasis on cancer. Curve has created an innovative screening platform that allows for the functional screening of genetically encoded Microcycleâ„¢ libraries against a variety of disease-associated targets in their native conformation within mammalian cells. This platform is designed to facilitate the discovery of first-in-class therapeutics, enabling the development of a pipeline of novel cancer drugs. By targeting challenging cancer interactions, including intracellular protein-protein and protein-gene interactions, Curve Therapeutics aims to deliver advanced treatments for complex cancer-related conditions.

Quantexa

Series E in 2023
Quantexa Limited is a data and analytics software company based in London, United Kingdom, that specializes in entity resolution and network building technology. Founded in 2016, the company offers solutions that include a unified view of customers and networks, as well as tools for fraud detection, compliance, and anti-money laundering. Quantexa's platform utilizes artificial intelligence to integrate siloed data and provide organizations with a contextual understanding of their data landscape, helping to identify risks and opportunities. This technology enables clients across financial services, corporate sectors, and public entities to enhance operational decision-making by automating processes at scale. Additionally, Quantexa has established a strategic alliance with Accenture to further extend its reach and capabilities in the market.

CyberSmart

Series B in 2023
CyberSmart Ltd. is a London-based company that specializes in designing and developing automated compliance software. Founded in 2016, the company offers a range of products including Cyber Essentials, Cyber Essentials Plus, GDPR Ready, and its flagship CyberSmart platform. This platform assists small to medium-sized businesses in identifying, addressing, certifying, and safeguarding against security incidents. Key features include the CE Smart tool, which identifies and certifies security incidents, and a cloud-based dashboard that manages compliance processes. Additionally, CyberSmart provides ongoing protection through regular security checks and cyber insurance coverage, ensuring that businesses can navigate the complexities of cybersecurity and regulatory compliance in a rapidly evolving digital landscape.

CloudNC

Series B in 2022
CloudNC Ltd. is a London-based company that specializes in developing software to automate the programming of computerized numerical control (CNC) milling machines. Established in 2015, CloudNC aims to modernize the manufacturing industry by creating advanced software that allows factories to autonomously produce precision parts, which are essential for various aspects of modern life, including automotive, aerospace, and electronics. The company's technology transforms CNC milling machines into user-friendly devices that require minimal human intervention, thus enhancing efficiency, reducing lead times, and increasing scalability for manufacturers. By focusing on automation and sustainability, CloudNC seeks to revolutionize the manufacturing process, making it ten times more efficient and positioning itself at the forefront of a $150 billion industry.

Quantexa

Series D in 2021
Quantexa Limited is a data and analytics software company based in London, United Kingdom, that specializes in entity resolution and network building technology. Founded in 2016, the company offers solutions that include a unified view of customers and networks, as well as tools for fraud detection, compliance, and anti-money laundering. Quantexa's platform utilizes artificial intelligence to integrate siloed data and provide organizations with a contextual understanding of their data landscape, helping to identify risks and opportunities. This technology enables clients across financial services, corporate sectors, and public entities to enhance operational decision-making by automating processes at scale. Additionally, Quantexa has established a strategic alliance with Accenture to further extend its reach and capabilities in the market.

Quantexa

Series C in 2020
Quantexa Limited is a data and analytics software company based in London, United Kingdom, that specializes in entity resolution and network building technology. Founded in 2016, the company offers solutions that include a unified view of customers and networks, as well as tools for fraud detection, compliance, and anti-money laundering. Quantexa's platform utilizes artificial intelligence to integrate siloed data and provide organizations with a contextual understanding of their data landscape, helping to identify risks and opportunities. This technology enables clients across financial services, corporate sectors, and public entities to enhance operational decision-making by automating processes at scale. Additionally, Quantexa has established a strategic alliance with Accenture to further extend its reach and capabilities in the market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.